Veramyst
These highlights do not include all the information needed to use VERAMYST safely and effectively. See full prescribing information for VERAMYST.VERAMYST (fluticasone furoate) Nasal SprayInitial U.S. Approval: 2007
Approved
Approval ID
8eaee9bf-91c7-484b-b8b1-b8242198181f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 1, 2010
Manufacturers
FDA
Physicians Total Care, Inc.
DUNS: 194123980
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
fluticasone furoate
PRODUCT DETAILS
NDC Product Code54868-6168
Application NumberNDA022051
Marketing CategoryC73594
Route of AdministrationNASAL
Effective DateSeptember 20, 2010
Generic Namefluticasone furoate
INGREDIENTS (8)
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
ANHYDROUS DEXTROSEInactive
Code: 5SL0G7R0OK
Classification: IACT
FLUTICASONE FUROATEActive
Quantity: 27.5 ug in 1 1
Code: JS86977WNV
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT